Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2400063	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2024-03-13		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHZ2400062	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2024-03-13		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHZ2400061	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2024-03-13		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHZ2400060	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2024-03-13		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHZ2100041	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2021-03-04	辉凌医药咨询（上海）有限公司	Ferring Pharmaceuticals(Asia) Co Ltd;Ferring International Center SA;Ferring GmbH	Certificate Issued	2021-09-27	view
JYHZ1900171	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2019-07-01	深圳市康哲药业有限公司	Shenzhen Kangzhe Pharmaceutical Co Ltd;Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH	Certificate Issued	2019-11-29	view
JYHZ1900170	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2019-06-21	深圳市康哲药业有限公司	Shenzhen Kangzhe Pharmaceutical Co Ltd;Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH	Certificate Issued	2019-11-29	view
JYHZ1900168	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2019-07-01	深圳市康哲药业有限公司	Shenzhen Kangzhe Pharmaceutical Co Ltd;Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH	Certificate Issued	2019-11-29	view
JYHZ1900167	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2019-07-01	深圳市康哲药业有限公司	Shenzhen Kangzhe Pharmaceutical Co Ltd;Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH	Certificate Issued	2019-11-29	view
JYHZ0800113	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2008-03-24	深圳市康哲药业有限公司	Shenzhen Kangzhe Pharmaceutical Co Ltd;Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH	Certificate Issued	2010-03-10	view
JYHZ0800112	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2008-03-24	深圳市康哲药业有限公司	Shenzhen Kangzhe Pharmaceutical Co Ltd;Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH	Certificate Issued	2010-03-10	view
JYHZ0700132	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	License Renew	2007-07-18	辉凌（德国）制药有限公司	Ferring GmbH;Pharbil Pharma GmbH	Certificate Issued	2008-10-30	view
JYHB2400109	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2024-02-29		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHB2400108	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2024-02-29		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHB2400107	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2024-02-29		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHB2400106	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2024-02-29		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHB2300671	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2023-11-22		Ferring International Center SA;Ferring GmbH			view
JYHB2101624	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2022-01-05		Ferring International Center SA;Ferring GmbH			view
JYHB2101386	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2021-09-01		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view
JYHB2101385	美沙拉秦栓	mesalazine	Suppository	Chemical Drugs	Supplementary Application	2021-09-01		Corden Pharma Fribourg AG Zweigniederlassung Ettingen;Dr Falk Pharma GmbH			view